Prediction of progression of non-muscle invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: A prospective study

被引：0
|
作者：
Zwarthoff, Ellen
Burger, Maximilian
Van der Aa, Madelon
Van Oers, Johanna
Brinkmann, Anke
Van der Kwast, Theodorus
Steyerberg, Ewout
Stoehr, Robert
Kirkels, Wim
Denzinger, Stefan
Wild, Peter
Wieland, Wolf
Hofstaedter, Ferdinand
Hartmann, Arndt
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Univ Regensburg, Regensburg, Germany
[3] Toronto Gen Hosp, Toronto, ON, Canada
[4] Univ Hosp Zurich, Zurich, Switzerland
[5] Univ Erlangen Nurnberg, Erlangen, Germany
来源：
CANCER RESEARCH | 2008年 / 68卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4951
引用
收藏
页数：2
相关论文
共 50 条
  • [21] SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer
    Lindgren, Maria Skydt
    Lamy, Philippe
    Lindskrog, Sia Viborg
    Christensen, Emil
    Nordentoft, Iver
    Birkenkamp-Demtroder, Karin
    Ulhoi, Benedicte Parm
    Jensen, Jorgen Bjerggaard
    Dyrskjot, Lars
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 34 : 59 - 67
  • [22] AI-based identification of FGFR3 mutation status from routine histology slides of muscle-invasive bladder cancer
    Saillard, Charlie
    Bannier, Pierre-Antoine
    Mann, Philipp
    Maussion, Charles
    Matek, Christian
    Hartmann, Arndt
    Eckstein, Markus
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [23] Study on the Treatment of non-muscle invasive Bladder Cancer
    Rexer, H.
    UROLOGE, 2015, 54 (03): : 406 - 408
  • [24] OPTIMALIZATION OF NON-MUSCLE-INVASIVE BLADDER CANCER RECURRENCE DETECTION USING A URINE-BASED FGFR3 MUTATION ASSAY
    Zuiverloon, T. C. M.
    Tjin, S. S.
    Busstra, M.
    Bangma, C. H.
    Boeve, E. R.
    Zwarthoff, E. C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 197 - 197
  • [25] TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
    Kawahara, Takashi
    Kojima, Takahiro
    Kandori, Shuya
    Kurobe, Masahiro
    Yoshino, Takayuki
    Kimura, Tomokazu
    Nagumo, Yoshiyuki
    Ishituka, Ryutaro
    Mitsuzuka, Koji
    Narita, Shintaro
    Kobayashi, Takashi
    Matsui, Yoshiyuki
    Ogawa, Osamu
    Sugimoto, Mikio
    Miyazaki, Jun
    Nishiyama, Hiroyuki
    PLOS ONE, 2019, 14 (08):
  • [26] GATA2 methylation and FGFR3 mutation predict progression in BCG-treated high-risk non-muscle-invasive bladder cancer
    Olislagers, M.
    De Jong, F. C.
    Van Etten, V. M. J.
    Kan, T. W.
    Zuiverloon, T. C. M.
    EUROPEAN UROLOGY, 2023, 83 : S405 - S406
  • [27] Impact of bladder neck involvement on progression in patients with non-muscle invasive bladder cancer: A validation study
    Kobayashi, S.
    Fujii, Y.
    Koga, F.
    Yokoyama, M.
    Sakura, M.
    Ishioka, J.
    Matsuoka, Y.
    Numao, N.
    Saito, K.
    Masuda, H.
    Kihara, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E963 - U22
  • [28] Upregulation of FGFR3 and HIF-1α expression in muscle invasive bladder cancer
    Warli, Syah Mirsya
    Laksmi, Lidya Imelda
    Safriadi, Ferry
    Umbas, Rainy
    MEDICAL JOURNAL OF INDONESIA, 2019, 28 (01) : 3 - 7
  • [29] FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?
    van Rhijn, Bas W. G.
    Mertens, Laura S.
    Mayr, Roman
    Bostrom, Peter J.
    Real, Francisco X.
    Zwarthoff, Ellen C.
    Boormans, Joost L.
    Abas, Cheno
    van Leenders, Geert J. l H.
    Gotz, Stefanie
    Hippe, Katrin
    Bertz, Simone
    Neuzillet, Yann
    Sanders, Joyce
    Broeks, Annegien
    van der Heijden, Michiel S.
    Jewett, Michael A. S.
    Marquez, Mirari
    Stoehr, Robert
    Zlotta, Alexandre R.
    Eckstein, Markus
    Soorojebally, Yanish
    Roshani, Hossain
    Burger, Maximilian
    Otto, Wolfgang
    Radvanyi, Francois
    Sirab, Nanor
    Pouessel, Damien
    Wullich, Bernd
    van der Kwast, Theo H.
    Malats, Nuria
    Hartmann, Arndt
    Allory, Yves
    Zuiverloon, Tahlita C. M.
    EUROPEAN UROLOGY, 2020, 78 (05) : 682 - 687
  • [30] PREDICTION OF RECURRENCE AND PROGRESSION IN THE CONTEXT OF THE CHARLSON COMORBIDITY INDEX IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
    Yang, Serena
    Chen, Guoqing
    Godoy, Guilherme
    Lerner, Seth
    JOURNAL OF UROLOGY, 2013, 189 (04): : E729 - E729
12345